As previously mentioned, AML cells with a more monocytic AML cell type or the FLT3, RAS, PTPN11 or TP53 mutations have increased dependency on MCL-1 instead of on BCL-2 [90,100,101,110,120]. This evidence concerns the gene FLT3 and acute myeloid leukemia.